In the same vein, experts recommend using other biologics with lesser risk of tuberculosis such as ustekinumab for psoriatic arthritis or rituximab for rheumatoid arthritis after tuberculosis treatment instead of TNF inhibitor reinitiating [17]. The gene discussed is TNF; the disease is psoriatic arthritis.